Clinical studies with solvent detergent-treated products
Author:
- 31 October 1996
- journal article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 10 (4) , 303-311
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Transfusion‐transmitted human parvovirus B19 infection in a thalassemic patientTransfusion, 1995
- Tolerability and Kinetics of a Solvent‐Detergent‐Treated Intravenous Immunoglobulin Preparation in Hypogammaglobulinaemia PatientsVox Sanguinis, 1995
- Hepatitis C virus infection in hypogammaglobulinemic patients receiving long‐term replacement therapy with intravenous immunoglobulinTransfusion, 1995
- Has Hepatitis A Virus Been Transmitted by Clotting Factor Concentrates among Hemophiliacs in the United States?Vox Sanguinis, 1994
- Review of the Hepatitis A Epidemics in Hemophiliacs in EuropeVox Sanguinis, 1994
- Virology of the Hepatitis A Epidemic in ItalyVox Sanguinis, 1994
- Low risk of transmission of the human immunodeficiency virus by a solvent‐detergent‐treated commercial factor VIII concentrateJournal of Medical Virology, 1992
- Transmission of Human Parvovirus B19 by Coagulation Factor ConcentratesVox Sanguinis, 1990
- Virus‐inactivated factor VIII concentrate prevents postoperative bleeding in a patient with von Willebrand's diseaseTransfusion, 1988
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1982